GB00BGLP8L22 (GB00BGLP8L22)

$6.6B
Market Cap
21.6
P/E Ratio
1.05
Beta
1.26%
Dividend Yield
Piotroski 8/9Altman Z 5.1 SafeROIC−WACC +9.9%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 5.1 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates robust fundamental quality, evidenced by a 20.7% ROIC that generates a substantial +9.9% spread over the cost of equity at 10.8%. This high-return profile is underpinned by exceptional profitability metrics, specifically a gross margin of 47.5% and a net margin of 13.5%, indicating strong pricing power or operational leverage rather than reliance on financial engineering. The DuPont decomposition points clearly toward margins as the primary driver of returns given the lack of explicit turnover or leverage data to suggest otherwise. Further reinforcing this structural strength, the company exhibits an elite Piotroski F-Score of 8/9 and a healthy Altman Z-Score of 5.1, signaling superior financial stability and low distress risk relative to historical norms.

Valuation analysis reveals a current P/E multiple of 21.6x against a DCF-derived fair value of $25 per share. While the specific sector average is not provided for direct comparison, the implied growth rate required to justify the current market price appears constrained given the modest revenue expansion of only 4.2% year-over-year. The gap between the stated P/E and the discounted cash flow model suggests that either the market anticipates a significant acceleration in future earnings power beyond recent trends or is pricing in higher risk premiums than reflected in the base case assumptions. Investors must weigh whether the current valuation adequately compensates for the slow top-line growth relative to the high quality of capital returns being generated today.

Risk assessment highlights a divergence between fundamental strength and momentum, as indicated by the lack of provided Fama-French alpha or insider activity data. The combination of low revenue growth with high profitability creates a classic "value trap" scenario if earnings cannot expand meaningfully in subsequent periods to support the 21.6x multiple. Conversely, any catalyst driving top-line acceleration could rapidly re-rate the stock higher given its efficient capital structure. Without additional information on beta or insider positioning, the risk/reward profile hinges entirely on the market's ability to price future growth into an asset that currently trades at a premium to its recent performance trajectory but remains supported by strong balance sheet metrics.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8.8%10.8%12.8%
2%$30$23$18
3%$34$25$19
4%$41$28$21

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.8%, terminal growth 3%. Fair value $25 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.1
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

47.5%
Gross Margin
13.5%
Net Margin
20.7%
ROIC
10.8%
WACC
ROIC − WACC Spread: +9.9%— Positive value creation spread.
+4.3%
Revenue Growth (YoY)
+24.7%
Earnings Growth (YoY)
316.6M
Free Cash Flow
25%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.24x
Debt / Equity
1.50x
Current Ratio
15.9x
Interest Coverage
0.6x
Net Debt / EBITDA
4.60%
FCF Yield
560.0M
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.6
Forward P/E
PEG Ratio
594.68
Price/Book
940586
Avg Volume
$2938.00
52W High
$1555.96
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$96M
Tracked Passive Exposure
3
ETFs Holding GB00BGLP8L22
0.03%
Avg Weight in ETFs
$278B
Total ETF AUM

When investors buy or sell ETFs like IEFA or SCHF, the fund manager is mechanically forced to buy or sell GB00BGLP8L22 shares regardless of GB00BGLP8L22's individual fundamentals. We estimate $96M of passive capital is structurally linked to GB00BGLP8L22 through 3 tracked ETFs. Passive flows have a limited but growing influence on GB00BGLP8L22's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 3 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in GB00BGLP8L22 to visualize passive redemption contagion across ETFs and collateral stocks.

GB00BGLP8L22 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
GB00BGLP8L22EpicenterIEFAETFSCHFETFIXUSETFNL0010273215Low RiskTW0002330008Low RiskCH0012032048Low RiskCH0012005267Low RiskKR7005930003Low Risk
GB00BGLP8L22 Price Drop (%)0

If GB00BGLP8L22 (GB00BGLP8L22) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 2 ETFs with GB00BGLP8L22. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 3 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

GB00BGLP8L22 Ownership Dynamics

Ticker
GB00BGLP8L22

Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

GB00BGLP8L22 Capital Efficiency

How efficiently does GB00BGLP8L22 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$317M
EBITDA
$560M
FCF Conversion
57%
Reinvestment Rate
43%
57% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
20.7%
ROIC − WACC Spread
9.9%

GB00BGLP8L22 converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The positive ROIC-WACC spread of 9.9% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare GB00BGLP8L22 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.